Current Topics in Medicinal Chemistry


Jia Zhou
Chemical Biology Program
Department of Pharmacology and Toxicology
University of Texas Medical Branch
Galveston, TX

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 4 Issue: 4, February

Preface [Hot topic: Modern Aspects in the Design And Discovery of Novel Antihypertensive Drugs (Guest Editor: Thomas Mavromoustakos)]

Volume:4   Issue: 4
Pp: i-i
Thomas Mavromoustakos
DOI: 10.2174/1568026043451366
Published on: 01 March, 2012

Conformation and Bioactivity. Design and Discovery of Novel Antihypertensive Drugs

Volume:4   Issue: 4
Pp: 385-401
T. Mavromoustakos, M. Zervou, P. Zoumpoulakis, I. Kyrikou, N. P. Benetis, L. Polevaya, P. Roumelioti, N. Giatas, A. Zoga and P. Moutevelis Minakakis
DOI: 10.2174/1568026043451302
Published on: 01 March, 2012

Structural Features of Angiotensin-I Converting Enzyme Catalytic Sites: Conformational Studies in Solution, Homology Models and Comparison with Other Zinc Metallopeptidases

Volume:4   Issue: 4
Pp: 403-429
Georgios A. Spyroulias, Athanassios S. Galanis, George Pairas, Evy Manessi-Zoupa and Paul Cordopatis
DOI: 10.2174/1568026043451294
Published on: 01 March, 2012

On the Structural Basis of the Hypertensive Properties of Angiotensin II: A Solved Mystery or a Controversial Issue?

Volume:4   Issue: 4
Pp: 431-444
Andreas G. Tzakos, Ioannis P. Gerothanassis and Anastassios N. Troganis
DOI: 10.2174/1568026043451375
Published on: 01 March, 2012

Efforts to Understand the Molecular Basis of Hypertension Through Drug:Membrane Interactions

Volume:4   Issue: 4
Pp: 445-459
T. Mavromoustakos, P. Zoumpoulakis, I. Kyrikou, A. Zoga, E. Siapi, M. Zervou, I. Daliani, D. Dimitriou, A. Pitsas, C. Kamoutsis and P. Laggner
DOI: 10.2174/1568026043451339
Published on: 01 March, 2012

Simulating Physiology and Methods for Therapeutic Evaluation with Emphasis on Hypertension

Volume:4   Issue: 4
Pp: 461-471
A. K. Macpherson and S. Neti
DOI: 10.2174/1568026043451357
Published on: 01 March, 2012

Hematocrit-lowering Effect Following Inactivation of Renin-Angiotensin System with Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers

Volume:4   Issue: 4
Pp: 483-486
K. P. Marathias, B. Agroyannis, T. Mavromoustakos, J. Matsoukas and D. V. Vlahakos
DOI: 10.2174/1568026043451311
Published on: 01 March, 2012

The Shift in the “Paradigm” of the Pharmacology of Hypertension

Volume:4   Issue: 4
Pp: 487-498
Christodoulos S. Flordellis, Dimitrios Goumenos, George Kourounis, Sotirios A. Tsementzis, Herve Paris and Jaannis Vlachojiannis
DOI: 10.2174/1568026043451348
Published on: 01 March, 2012